Topics
Every story is filed under one category and tagged by subject. Pick one to see everything filed there, newest first.
Categories
-
Approvals
Decisions by the FDA and other regulators on new drugs, biologics and devices.
58 stories
-
Clinical trials
Trial starts, readouts, holds and designs.
267 stories
-
Regulation
Rules, guidance and how the agencies work.
68 stories
-
Policy
Law, pricing, reimbursement and public health policy.
50 stories
-
Business
The business of the industry: deals, pricing, vendors and CROs, recruitment.
5 stories
Tags
- [18F]FET 1
- 2026 1
- 2028 coverage 1
- 3Rs 1
- Abbisko Therapeutics 1
- Abbott 3
- ABBV-2294 1
- ABBV-706 1
- AbbVie 6
- ABC008 1
- Abcuro, Inc. 1
- Acadia Pharmaceuticals Inc. 1
- ACCESS 2 1
- Accord Healthcare S.L.U. 1
- ACE723 1
- Acepodia 1
- Acetaminophen/Naproxen Sodium Fixed Combination 1
- achondroplasia 3
- Acne Vulgaris 1
- Actinium Pharmaceuticals 1
- Acute Ischemic Stroke 1
- Acute Otitis Externa 1
- AD04 1
- AD109 1
- Adaptive Sensory Technology 1
- Adriana Coll De Peña 1
- Advanced Cancer 1
- ADvantage 1
- advisory committees 1
- AFFIRM 1
- Afimetoran 1
- Age-Related Macular Degeneration 1
- Agilera 1
- aHUS 1
- AiSync 1
- Alaunos 1
- Alcon 2
- Alectinib 1
- Alexion 2
- ALK 1
- ALK7 1
- Almirall 1
- ALN-CIDEB 1
- ALS 2
- AMA 1
- Amgen 6
- amivantamab 2
- Amneal Pharmaceuticals 1
- Amneal Pharmaceuticals of New York, LLC 1
- AmyriAD 1
- Amyris 1
- ANA-1 2
- Anaheim Bio 2
- Analysis 5
- ANDA 1
- ANDAs 1
- ANDEMBRY 1
- Androgenetic Alopecia 1
- anitocabtagene autoleucel 1
- Anktiva 2
- Antengene 1
- antibody-drug conjugates 1
- Antithrombin III Deficiency 1
- ANZUPGO 1
- Apellis Pharmaceuticals 2
- APHRS 1
- apitegromab-mstn 1
- APMR 1
- Apnimed 1
- Apogee 1
- Approvals 1
- apraclonidine 1
- Apraclonidine HCl 1
- Apraclonidine Hydrochloride Ophthalmic Solution 1
- Argá Medtech 1
- ARTISTRY-1 1
- Ascendis Pharma 1
- Ascendis Pharma A/S 1
- Ascendis Pharma Growth Disorders A/S 1
- ASKA Pharmaceutical 1
- ASPIRE-HF 1
- Astegolimab 1
- Asthma 2
- AstraZeneca 7
- AstraZeneca AB 1
- asundexian 1
- AT-III concentrate 1
- Atacicept 1
- Ataluren 1
- atezolizumab 4
- ATG-201 1
- Aticaprant 1
- atirmociclib 1
- Atopic Dermatitis 4
- ATTRACT 1
- Aumseqa 2
- Awiqli 1
- Axatilimab 1
- Azafaros 1
- AZD6234 1
- B-cell-mediated autoimmune diseases 1
- Babies and Young Children 1
- Bausch Health 1
- baxdrostat 1
- Baxfendy 2
- Bayer 1
- Bayer HealthCare Pharmaceuticals Inc. 1
- BCG-unresponsive NMIBC 1
- BCI 1
- BCR 1
- BDBV 1
- Beeline Medicines Corporation 1
- Benign Prostatic Hyperplasia 1
- BEOVU 1
- bepirovirsen 1
- Berobenatide 1
- bevacizumab 1
- Bexsero 1
- BHV-1300 1
- Bictegravir 1
- Bictegravir/Lenacapavir 1
- Biktarvy 1
- Bimatoprost SR 1
- Bimeda Animal Health Ltd. 1
- BioArctic 2
- Biohaven Therapeutics Ltd. 1
- BioMarin 3
- biosimilar 1
- biosimilars 2
- Biosplice Therapeutics, Inc. 1
- Biotech Act 1
- BIZENGRI 1
- Bladder cancer 1
- Blood establishments 1
- BMN 333 1
- Boehringer Ingelheim 7
- Brain Metastasis 1
- BrainTransporter 1
- Breast cancer 3
- brentuximab vedotin 1
- Brigham and Women's Hospital 1
- BRINSUPRI 1
- Brise Pharmaceuticals 1
- Bristol Myers Squibb 2
- brolucizumab-dbll 1
- Bronchiectasis 1
- Brytly 1
- Bundibugyo virus 1
- BXCL501 1
- C3 Glomerulopathy 1
- C9ORF72 1
- Cadmium 1
- CagriSema 1
- camrelizumab 1
- CAPOX 1
- Carbetocin 1
- carboplatin 1
- Cardiology 3
- Cardiovascular Disease 2
- CBER 1
- CDRH 1
- ceftobiprole 1
- Celecoxib 1
- cellular and gene therapy 1
- Cellular and Gene Therapy Products 1
- Center for Biologics Evaluation and Research 1
- Center for Drug Evaluation and Research 1
- Cephea 1
- Cerezyme 1
- CERVINO 1
- cGVHD 1
- Chapter 12 1
- CheckMate 8HW 1
- CHF5993 1
- Chiesi Farmaceutici S.p.A. 1
- Childhood Idiopathic Nephrotic Syndrome 1
- CHMP 6
- CHOICE Arrangement 1
- CHOICE Arrangements 1
- Ciprofloxacin-Fluocinolone Acetonide 1
- CKD 3
- class ii 2
- Climara Pro 1
- Clinical operations 1
- clinical toxicology test systems 1
- Clinical trials 9
- Clinical Trials Information System 1
- CM313 1
- CM336 1
- CMA2 1
- CMS 21
- CNS Summit 1
- Coartem 1
- cobas e801 1
- cobas eplex respiratory pathogen panel 3 1
- Cognixion 1
- COHERENT-AF 1
- Cold Spring Harbor Laboratory 1
- Colgate Palmolive 1
- Colon cancer 1
- companion software 1
- Company news 1
- Congestion 1
- consumer representatives 1
- COPD 6
- CPPD 2
- CPT 43498 1
- CPT 45991 1
- CRISPR 1
- CRO and CDMO 1
- Crohn's disease 2
- Crovalimab 1
- CROWN-MV 1
- CSA-AKI 1
- CSE Platform 1
- CSPC Megalith Biopharmaceutical 1
- CuraTeQ Biologics 1
- Cutaneous Lupus Erythematosus 1
- CY 2027 2
- Cystic Fibrosis 1
- DAHLIAS 1
- Dapagliflozin 1
- daraxonrasib 2
- Dasiglucagon 1
- Data stories 23
- David W. Gibbs 1
- dazodalibep 1
- DBV Technologies 2
- DBV712 1
- Deanxit 1
- DeLLphi-304 1
- Dementia 1
- denifanstat 1
- Depression 1
- Dermatology 2
- Desmoid Tumors 1
- Deutenzalutamide 1
- Devices Intended To Deliver Drugs and Biological Products 1
- Dexa Medica Group 1
- Dexmedetomidine 1
- Diabetes 2
- dialysis 1
- diclofenac epolamine 1
- Divarasib 1
- DLBCL 3
- DLBS3233 1
- DME 1
- dMMR colon cancer 1
- Donrafylix 2
- dostarlimab 1
- Double Helix Medals 1
- Droia Ventures 2
- Drug pricing 1
- DTX401 1
- Dualase 1
- Duchenne Muscular Dystrophy 2
- Dupilumab 1
- Durvalumab 3
- Dyspareunia 1
- Early-Phase IND Protocol Recommendations for Solid Tumors 1
- ECHELON-3 1
- Efluelda/Fluzone 1
- EHR 1
- Ehtiwaa 1
- Eisai 1
- Elanco US Inc. 1
- Eli Lilly and Company 7
- Eligibility 1
- EloraTZP 3
- ELX/TEZ/IVA 1
- EMA 5
- EMCITATE 1
- Emmanuel Janssen Endowed Chair 1
- Endotrophin 1
- enfortumab vedotin-ejfv 1
- ENHANCE-3 1
- enicepatide 2
- enlonstobart 1
- Enrollment 1
- ensifentrine 1
- Environmental Defense Fund 1
- enzalutamide 2
- eosinophilic esophagitis 1
- epcoritamab 2
- Equiniti Trust Company 1
- ER+ 1
- Erectile Dysfunction 1
- Erectile Dysfunctions 1
- Erenumab 1
- Erythrodermic Psoriasis 1
- ESD 1
- ESG Reporting Awards 1
- ESG Risk Rating 1
- ESMO 1
- ESMO 2026 1
- esophageal squamous cell carcinoma 1
- ESR1 1
- ESRD 1
- ESRD PPS 1
- Essential Drug Delivery Performance Characteristics 1
- estradiol and levonorgestrel transdermal system 1
- Etentamig 1
- ethylene dichloride 1
- everolimus 1
- Evumed Limited 1
- Exchange Pre-Eligibility Verification 1
- External Mechanical Stimulator 1
- Fabry disease 1
- Facial Toner 1
- Familial Mediterranean Fever 1
- famotidine 1
- FAYUVI 1
- FDA 70
- FDA approvals 3
- FDC laroprovstat/rosuvastatin 1
- fibrotic lung disease 1
- FID 123320 1
- filgrastim 1
- Financing 1
- Finerenone 1
- Flebogamma DIF 1
- FLOT 1
- flushing and storage solution 1
- focused ultrasound system 1
- Fondaparinux sodium Evumed 1
- Forbes China ESG 50 1
- fordadistrogene movaparvovec 1
- Foundayo 3
- Fovlussea 1
- Fresenius 1
- FrieslandCampina 1
- FUZION 1
- GALAFOLD 1
- Garzulys 1
- Gaucher's Disease Type III 1
- Gazyva 1
- GC Biopharma Corp 1
- GC/GEJC 1
- GC3114B 1
- Gene therapy 1
- Generalized Anxiety Disorder 1
- Generalized Pustular Psoriasis 1
- Genetic Obesity 1
- Genmab 3
- Geographic Atrophy 1
- GEP-NECs 1
- Gilead Sciences 2
- gingivitis 1
- giredestrant 2
- GL Pharm Tech Corporation 1
- Glabellar Lines 1
- GlaxoSmithKline 5
- glioblastoma 1
- Glucagon 1
- Gocatamig 1
- Goflikicept 1
- Goochland County 1
- Good Molecules 1
- Gout 1
- Grade 2 Glioma 1
- Graves' Disease 1
- GSDIa 1
- GSK plc 1
- Guangzhou Patronus Biotech Co., Ltd. 1
- guidance 1
- GVHD 1
- H. Pylori 1
- Halozyme 1
- Hanmi Pharmaceutical Company Limited 1
- Harmony Biosciences 1
- Hazard Analysis 1
- HCC 1
- Head and Neck Cancer 2
- head and neck squamous cell carcinoma 1
- Health insurance 1
- Hematology 2
- hematopoietic cell enrichment kit 1
- Hepatic Encephalopathy 1
- Hepatitis B 3
- HER2-positive breast cancer 1
- HER3 1
- HERA 1
- herpes simplex virus 1
- HFA-134a 1
- HFA-152a 1
- HFOV 1
- HFpEF 1
- Hibsago 1
- Hidradenitis Suppurativa 2
- Hims & Hers 1
- Hinova Pharmaceuticals Inc 1
- HIP2602 1
- HistoSonics 1
- HIV 2
- HIV-1 1
- HLX37 1
- HM15421/GC1134A 1
- HMPL-306 1
- HNSCC 2
- Hoffmann-La Roche 9
- Home Health 2
- Hovilpri 1
- HRS-6209 1
- HS-10382 1
- HSCT-TMA 1
- HU-045 1
- human normal immunoglobulin 1
- Huons Biopharma 1
- Hutchmed 1
- hyaluronidase-lpuj 1
- Hypercholesterolemia 1
- hyperoxia monitoring device adjunct to pulse oximetry 1
- Hyperpigmentation 1
- Hypertension 1
- hypochondroplasia 1
- Hypogonadism 1
- ibogaine 2
- IBSA Institut Biochimique SA 1
- ICMRA 1
- icotrokinra 1
- ICOTYDE 1
- iCVID 1
- IDE 1
- IDEA Pharma 1
- Idiopathic Hypersomnia 2
- Idiopathic Pulmonary Fibrosis 1
- IDR 1
- IgA Nephropathy 3
- IGF-1R 1
- IIV-HD 1
- Il-Yang Pharm. Co. 1
- Ilya Yuffa 1
- Immunoglobulin A Nephropathy 1
- Immunology 1
- Immunotherapy 1
- IMpower030 1
- Improper Payments 1
- IMVEXXY 1
- IMVIONIX 1
- Inclusion Body Myositis 1
- Incyte 2
- inebilizumab 1
- Infant ALL 1
- infant formula 2
- infant pulse rate and oxygen saturation monitor 1
- Infectious Disease 5
- Influenza 1
- Influenza A 1
- Influenza B 1
- Innovent Biologics 1
- Inovio 1
- Instituto Grifols 1
- insulin degludec 1
- Insulin glargine 1
- insulin icodec-abae 1
- interchangeable biosimilar 1
- Intra-Cellular Therapies, Inc. 2
- iodine 1
- Ionis Pharmaceuticals 1
- ipilimumab 1
- ISEMBYLD 1
- ISTURISA 1
- ISTx 1
- Itepekimab 2
- ITI-1284 1
- IVL 1
- Izalontamab brengitecan 1
- Jade Biosciences 1
- JADE101 1
- JAMA 1
- Janssen Research & Development, LLC 4
- Jaypirca 1
- Jemperli 1
- Jiangsu Hansoh Pharmaceutical Co., Ltd. 1
- Jiangsu HengRui Medicine 1
- Jiangsu HengRui Medicine Co., Ltd. 2
- Jiangsu Simcere Pharmaceutical Co., Ltd. 1
- Jiankuan (Suzhou) Biotechnology Company Limited 1
- JNJ-6143 1
- JNJ-9401 1
- JNJ-99245354 1
- Johnson & Johnson 6
- Johnson & Johnson Consumer Inc. 1
- JP-1366 1
- JPY 1
- KBP-5074 1
- Kevin Tracey 1
- Keymed Biosciences Co.Ltd 1
- KEYNOTE-522 1
- Keytruda 2
- Keytruda QLEX 2
- Kite 1
- Kizfizo 1
- KLU156 1
- KRAS 1
- KRAS G12C 1
- KRKA 1
- Kuraci BV 1
- L-MOCA 1
- Lantheus 1
- Large B-cell Lymphoma 1
- Leanne Morgan 1
- Lebrikizumab 2
- Lee's Pharmaceutical Limited 1
- Lenacapavir 1
- Leqembi 1
- LicartTM 1
- Lilac Biosciences 1
- Lilly 7
- Lilly Global Markets 1
- linerixibat 1
- Liraglutide 1
- LLSAT 1
- Locally Advanced Rectal Cancer 1
- lonapegsomatropin 1
- Long QT Syndrome 1
- Lumateperone 1
- Lung cancer 1
- LYB005 1
- Lymphoma 3
- Major Depressive Disorder 1
- Mammoth Biosciences 1
- maridebart cafraglutide 1
- Masimo Corporation 1
- MASLD 1
- MB-CasFire 1
- mCRPC 1
- MDD 1
- MDS-UPDRS 1
- MDT 1
- Medicaid 2
- Medical devices 1
- Medicare 3
- Medicare Advantage 2
- Medicare Drug Price Negotiation Program 3
- Medicare Part B 1
- Medicare Part D 1
- Medicare Physician Fee Schedule 1
- Medtech 1
- Medtronic 3
- MenACYW conjugate vaccine 1
- Meningitis 1
- Meningococcal Immunisation 1
- Merck KGaA 1
- Merck Sharp & Dohme LLC 3
- Meridian Medical Technologies 1
- Metabolic 1
- Metabolic Dysfunction-Associated Steatotic Liver Disease 1
- metastatic colorectal cancer 1
- metastatic pancreatic adenocarcinoma 1
- mFOLFOX6 1
- MHB018A 1
- Michael Milken 1
- Migraine 2
- mild cognitive impairment 1
- Minghui Pharmaceutical 1
- MiniMed 2
- Missouri 1
- mitapivat 1
- mitral valve disease 1
- MMED 1
- MMF 1
- MOBILion 1
- ModQuantTM 1
- MRD 1
- mRNA Seasonal Flu vaccine 1
- MTM Vision Consortium 1
- Multiple Myeloma 5
- muscle invasive bladder cancer 1
- navepegritide 2
- Navinta LLC 1
- NCT03959241 1
- NCT04630028 1
- NCT04775082 1
- NCT04963296 1
- NCT05093634 1
- NCT06109311 1
- NCT07136766 1
- NCT07854847 1
- NCT07855900 1
- NCT07885917 1
- NCT07885956 1
- NDI 1
- NEB 1
- Negotiation Program 1
- Nektar Therapeutics 1
- Nephrology 3
- Neurology 1
- Neuzafy 1
- Nexus Pharmaceuticals 1
- nicotinamide riboside 1
- NIDCD 1
- Nimenrix 1
- nipocalimab 1
- nivolumab 2
- nizubaglustat 1
- NKTR-255 1
- No Surprises Act 1
- nogapendekin alfa inbakicept-pmln 1
- Non-Segmental Vitiligo 1
- non-squamous NSCLC 1
- Nonclinical testing 1
- NOPARK 1
- Nordic Bioscience 1
- Novartis 3
- Novartis Pharmaceuticals 2
- Novatek 1
- Novavax 1
- Novo Nordisk 5
- NP-101 1
- NSCLC 7
- NSV 1
- Nurses for Nursing Homes 1
- nursing homes 2
- Nuvaxovid 1
- NVXC19 1
- OAG 1
- OASIS PEDIATRIC 1
- OASIZ-301 1
- Obesity 10
- Obinutuzumab 2
- Obrixtamig 1
- OCEANIC-STROKE 1
- Ocular Redness 1
- Olaparib 1
- Older adults 1
- Olomorasib 2
- Olympus 1
- Omvoh 1
- Oncodetect 1
- Oncology 19
- Onconic Therapeutics Inc. 1
- Oobli 1
- OPO 1
- Orforglipron 3
- organ procurement 1
- ORi 1
- Orphalan 1
- Orphelia Pharma 1
- orthopedic use 1
- OSA 1
- osilodrostat 1
- Ovarian Cancer 1
- Overweight 2
- P. falciparum malaria 1
- Pacibekitug 1
- paediatric intensive care units 1
- PAF 1
- PAI Pharma 1
- Paragon Labs 1
- Parkinson disease 1
- Part D 2
- pasritamig 1
- Patrik Jonsson 1
- PBC 1
- PD-L1 1
- PDGM 1
- Peanut Allergy 2
- Pediatric 2
- pediatric ulcerative colitis 1
- Pediatrics 4
- Pegcetacoplan 3
- Pembrolizumab 3
- pemetrexed 1
- Pepcid RPD 1
- PepsiCo 1
- PERSEE 1
- pertuzumab 1
- PF-08653944 1
- Pfizer 5
- PH-COPD 1
- Ph+ CML-CP 1
- PharmaLogic 1
- Pharmazz, Inc. 1
- Phase 1 1
- Phase 3 16
- pimicotinib 1
- Pimjetmi 2
- PINNACLE-MI 1
- pirtobrutinib 1
- Pitolisant 1
- plaque 1
- PNH 1
- Polycythemia Vera 1
- POMBILITI + OPFOLDA 1
- postoperative dental pain 1
- potency assurance 2
- Povetacicept 1
- povorcitinib 2
- PPD 1
- PRABITAS 1
- PRAC 2
- Prader-Willi Syndrome 1
- pralidoxime chloride 1
- Precigen 1
- Prediabetes 1
- Premier Research International 1
- Premium Rebate 1
- prescription drug apps 1
- Primary Immunodeficiency Diseases 1
- primary membranous nephropathy 2
- Priority review vouchers 2
- pritelivir 1
- Processed Food 1
- prognostic assessment software 1
- prone positioning 1
- PROSpect 1
- prostate cancer 3
- Protagonist Therapeutics 1
- proximod 1
- PsA 1
- Psoriatic Arthritis 2
- Psychiatry 1
- PT Bio Farma 1
- PTC Therapeutics 1
- PTCy 1
- PulseSelect 1
- Q&A I.20 1
- Qilu Pharmaceutical 1
- QLS4131 1
- Quetiapine XR 1
- R-Pharm 1
- radiology software 1
- Ramantamig 1
- ranibizumab 1
- Rare disease 8
- Rare Disease Framework Initiative 1
- Rare Thyroid Therapeutics International AB 1
- Rasonque 2
- Ravulizumab 2
- Ray Therapeutics 1
- RC118 1
- RC148 1
- RC28-E 1
- Reagan-Udall Foundation 1
- Recipharm Israel 1
- Recruitment 1
- rectal cancer 2
- Regeneron 2
- Regeneron Pharmaceuticals 1
- relatlimab 1
- RemeGen 2
- Respiratory 4
- RESTORE-TBI 1
- RET 1
- retatrutide 1
- Retinitis Pigmentosa 1
- Revolution Medicines 1
- Revolution Medicines Netherlands B.V. 1
- Rheumatoid Arthrits 1
- Rheumatology 1
- RHTP 1
- Rhythm Pharmaceuticals 1
- ribupatide 1
- Richmond 1
- Rifaximin SSD 1
- rilzabrutinib 1
- Rina-S 1
- RINGSIDE 1
- risankizumab 1
- RISE UP 1
- rMenB+OMV NZ 1
- Roche 3
- Roche Diagnostics 1
- Rona Therapeutics 1
- RRP 2
- RSV 2
- RSVpreF 1
- RTx-015 1
- Rural Health Transformation Program 1
- Rural Texas Strong 1
- Rusfertide 1
- Ruxolitinib Krka 1
- Rybrevant Faspro 4
- RZV 1
- Sagimet Biosciences Inc. 1
- salbutamol 1
- salt substitutes 1
- Samsung Biologics 1
- Sanofi 8
- Sanofi Pasteur 1
- Saudi Schizophrenia Association 1
- SBA 2
- SBS 1
- ScandiBio Therapeutics AB 1
- Schizophrenia 1
- Scholar Rock 1
- Scinai 1
- SCLC 1
- Seagen 1
- Sean Maenpaa 1
- Sebastian Schneeweiss 1
- Seltorexant 1
- semaglutide 2
- Seretide Evohaler 1
- Sergeant's Pet Care Products LLC 1
- Setmelanotide 1
- SFL Pharmaceuticals Deutschland GmbH 1
- Shanghai Henlius Biotech 1
- SHINE-2 1
- SHR-3167 2
- Sibeprenlimab 1
- sickle cell disease 1
- SIM0811 1
- Sintilimab 2
- Sirogen 1
- Sjögren's disease 2
- SKYRIZI 1
- Sleep medicine 1
- SLIM 1
- SM04554 1
- Small Cell Lung Cancer 1
- Small Wins 1
- Sofe-M 1
- Sofetabart mipitecan 1
- solid tumors 1
- SonicForce 1
- sovateltide 1
- Specific Biologics 1
- Sphere-9 1
- Springfield 1
- Stage III dMMR colon cancer 1
- standardized foods 1
- stannous fluoride 1
- Staphylococcus aureus 1
- Star Ratings 1
- sterile injectable 1
- STOP-V1 1
- STOP-V2 1
- Stream 353
- Stress urinary incontinence 1
- SUMMIT OLE 1
- Sunharbo 1
- Survodutide 3
- Sustainalytics 1
- Swedish Orphan Biovitrum 1
- sweet proteins 1
- Symbicort Aerosphere 1
- SYNCHRONIZE-CVOT 1
- Syneos Health 1
- SYS6010 1
- Systemic Lupus Erythematosus 1
- Systemic Sclerosis 1
- Tac/MTX 1
- TAK-279 1
- TAK-881 1
- Take Command 2
- Takeda 3
- TALAPRO-2 1
- talazoparib 2
- Taltz 2
- tarlatamab 1
- Tecentriq 2
- TECTONIC 1
- TED 1
- Telix Pharmaceuticals 1
- Temab-A 1
- temozolomide 1
- tenosynovial giant cell tumor 1
- Testosterone Cypionate 1
- TEV-53408 1
- Teva Branded Pharmaceutical Products R&D LLC 1
- Teva Pharmaceuticals 1
- Texas 1
- TEZSPIRE 1
- TGCT 1
- Thermo Fisher Scientific 1
- THRV-1268 1
- Thryv Therapeutics 1
- Tiotropium/Salmeterol 1
- Tiragolumab 1
- tirzepatide 1
- TMB-H 2
- TOGETHER-PsO 1
- TRADITiONAL 1
- Transfusion-Transmitted 1
- Transplant 1
- trastuzumab 1
- traumatic brain injury 1
- TREMFYA 1
- Treprostinil 1
- treprostinil SMI 1
- Trialbee 1
- Trialmed 1
- trichloroethylene 1
- trifluridine-tipiracil 1
- Triple Negative Breast Cancer 1
- TRITON 1
- tucatinib 1
- Type 1 Diabetes 2
- Type 2 Diabetes 7
- Type 2 Diabetes Mellitus 3
- type IA 1
- type IB 1
- U.S.-Origin Statements on Seafood 1
- UCB 1
- Ulcerative Colitis 2
- Ultragenyx 1
- Ultragenyx Pharmaceutical Inc. 1
- Under Armour 1
- UNION 1
- United Therapeutics 2
- Upadacitinib 1
- UROCOM-R1 1
- UROCOM-R2 1
- Ustekinumab 1
- Uzesta 1
- Vaccines 2
- Varegacestat 1
- vascular autografts 1
- Vascular Therapies 1
- Veeva Commercial Summit 1
- Veeva Systems 1
- Velaris 1
- venglustat 1
- Vera Therapeutics 1
- verducatib 2
- Vertex Pharmaceuticals Incorporated 2
- VESPER-SUI 1
- Viaskin Peanut 1
- Viking Therapeutics 2
- vitamin A 1
- Vitiligo 1
- VK2735 2
- Voceryq 1
- VOXZOGO 2
- W2505 1
- wAMD 1
- Waters 1
- wearable vibration device 1
- Weekly issues 7
- Weight Loss 2
- Wilson disease 1
- Women's health 1
- work requirement 1
- WuXi Biologics 2
- Xeomin 1
- Xevo 1
- Xtalks 2
- Yum! Brands 1
- Yuviwel 1
- ZANVASTRO 1
- Zasocitinib 1
- Zepbound 4
- zigakibart 1
- Zinzino 1
- Zoetis Inc. 1
- zopapogene imadenovec 1
- Zybrivo 2
- Zydus Pharmaceuticals 1